3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
11
Neoplasm Metastasis
3
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence Free Survival
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Histiocytosis
1
Fallopian Tube Neoplasms
1
Erythema
1
Endometrial Neoplasms
1
Edema
1
Breast Neoplasms
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Panitumumab
×
90 days
×
Clear all
No trials found.